发明名称 Methods and compounds for prevention of graft rejection
摘要 Disclosed is a method of localized immunosuppression which may be used for preventing graft rejection or for preventing tissue destruction due to autoimmune disease. Also disclosed is a protein suppressor factor that is secreted by cloned anergic T-cells, blocks interleukin 2 (IL-2) stimulated T-cell proliferation, has an apparent molecular weight of between 10 and 30 kilodaltons, can be inactivated by heating to 65° C. for 15 minutes, blocks interleukin 4 (IL-4) stimulated T-cell proliferation in vitro, is non-cytotoxic to T-cells, and does not inhibit the production of IL-2 by T-cells in vitro.
申请公布号 US2002164311(A1) 申请公布日期 2002.11.07
申请号 US20010804717 申请日期 2001.03.12
申请人 BETH ISRAEL HOSPITAL ASSOCIATION, A MASSACHUSETTS CORPORATION 发明人 STORM TERRY B.;LIBERMANN TOWIA
分类号 A61K38/00;A61K48/00;A61P37/06;C07K14/47;C07K14/495;C07K14/54;(IPC1-7):A61K48/00;C12N15/87 主分类号 A61K38/00
代理机构 代理人
主权项
地址